80644-0012 : Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution
NDC: | 80644-0012 |
Labeler: | Zealand Pharma Us, Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Zegalogue |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | NDA214231 |
Rev. Date: |
NDC Package Codes:
- 80644-0012-1: 1 CONTAINER IN 1 PACKAGE (80644‑0012‑1) > 1 SYRINGE, GLASS IN 1 CONTAINER > .6 ML IN 1 SYRINGE, GLASS
- 80644-0012-2: 2 PACKAGE IN 1 CARTON (80644‑0012‑2) > 1 CONTAINER IN 1 PACKAGE > 1 SYRINGE, GLASS IN 1 CONTAINER > .6 ML IN 1 SYRINGE, GLASS
Active Ingredients:
- Dasiglucagon
Dosage Strength:
- .6 mg/.6mL
Pharmaceutical Classes:
- Antihypoglycemic Agent [EPC]
- Glucagon Receptor Agonists [MoA]
- Increased Glycogenolysis [PE]
Related Products:
Based on records with the same trade name.- 80644-0013 Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution by Zealand Pharma Us, Inc
- 0169-1912 Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution by Novo Nordisk
- 0169-1913 Zegalogue .6 mg/.6ml Subcutaneous Injection, Solution by Novo Nordisk
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 80642-060Next: 80644-0013 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.